 |
|
Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
Sang Bong Ahn
Clin Mol Hepatol. 2023;29(Suppl):S150-S156. Published online 2023 Jan 25 DOI: https://doi.org/10.3350/cmh.2022.0362
|
|
Citations to this article as recorded by
 Performance of Noninvasive Indices for Discrimination of Metabolic Dysfunction-Associated Steatotic Liver Disease in Young Adults
Jaejun Lee, Chang In Han, Dong Yeup Lee, Pil Soo Sung, Si Hyun Bae, Hyun Yang
Gut and Liver.2025; 19(1): 116. CrossRef Noninvasive identification of metabolic dysfunction–associated steatohepatitis (INFORM MASH): a retrospective cohort and disease modeling study
G. Craig Wood, Anthony Hoovler, Rakesh Luthra, Christopher D. Still, Hamzah Shariff, Matthew Still, Jonathan Hayes, Peter Benotti, Chioma Uzoigwe
Expert Review of Gastroenterology & Hepatology.2025; 19(4): 427. CrossRef Updated recommendations for the management of metabolic dysfunction–associated steatotic liver disease (MASLD) by the Latin American working group.
Luis Antonio Diaz, Juan Pablo Arab, Francisco Idalsoaga, Javiera Perelli, Javier Vega, Melisa Dirchwolf, Javiera Carreño, Bárbara Samith, Cynthia Valério, Rodrigo Oliveira Moreira, Mónica Acevedo, Javier Brahm, Nelia Hernández, Adrian Gadano, Claudia P. O
Annals of Hepatology.2025; : 101903. CrossRef Atherogenic index of plasma identifies subjects with severe liver steatosis
Carlo De Matteis, Fabio Novielli, Ersilia Di Buduo, Maria Arconzo, Raffaella Maria Gadaleta, Marica Cariello, Antonio Moschetta, Lucilla Crudele
Scientific Reports.2025;[Epub] CrossRef Construction and evaluation of a diagnostic model for metabolic dysfunction-associated steatotic liver disease based on advanced glycation end products and their receptors
Xiao Cao, Xiaohua Xiao, Peipei Jiang, Nian Fu
Frontiers in Medicine.2025;[Epub] CrossRef Analysis the Mechanism of Herba Artemisiae scopariae and Folium nelumbinis in the Treatment of Non-Alcoholic Fatty Liver
Disease Based on Network Pharmacology
鑫凤 娄
Traditional Chinese Medicine.2025; 14(04): 1253. CrossRef The interplay of metabolic dysfunction‐associated fatty liver disease and viral hepatitis on liver disease severity: A large community‐based study in a viral endemic area
Chung‐Feng Huang, Po‐Cheng Liang, Pei‐Chien Tsai, Yu‐Ju Wei, Ching‐I Huang, Chih‐Wen Wang, Tyng‐Yuan Jang, Ming‐Lun Yeh, Po‐Yao Hsu, Ming‐Yen Hsieh, Yi‐Hung Lin, Chia‐Yen Dai, Wan‐Long Chuang, Jee‐Fu Huang, Ming‐Lung Yu
Journal of Gastroenterology and Hepatology.2024; 39(1): 193. CrossRef Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies
Mohammad Habibullah, Khaleed Jemmieh, Amr Ouda, Mohammad Zulqurnain Haider, Mohammed Imad Malki, Abdel-Naser Elzouki
Frontiers in Medicine.2024;[Epub] CrossRef Prevalence of at‐risk MASH, MetALD and alcohol‐associated steatotic liver disease in the general population
Carolin V. Schneider, Kai Markus Schneider, Anastasia Raptis, Helen Huang, Christian Trautwein, Rohit Loomba
Alimentary Pharmacology & Therapeutics.2024; 59(10): 1271. CrossRef Type 2 diabetes mellitus and cardiometabolic outcomes in metabolic dysfunction-associated steatotic liver disease population
Nicholas W.S. Chew, Xin Hui Pan, Bryan Chong, Chanchal Chandramouli, Mark Muthiah, Carolyn S.P. Lam
Diabetes Research and Clinical Practice.2024; 211: 111652. CrossRef High-Sensitivity C-Reactive Protein Levels in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Metabolic Alcohol-Associated Liver Disease (MetALD), and Alcoholic Liver Disease (ALD) with Metabolic Dysfunction
Seong-Uk Baek, Jin-Ha Yoon
Biomolecules.2024; 14(11): 1468. CrossRef Fatty Acids and Bilirubin as Intrinsic Autofluorescence Serum Biomarkers of Drug Action in a Rat Model of Liver Ischemia and Reperfusion
Anna C. Croce, Andrea Ferrigno, Giuseppina Palladini, Barbara Mannucci, Mariapia Vairetti, Laura G. Di Pasqua
Molecules.2023; 28(9): 3818. CrossRef The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
Teodora Biciusca, Sorina Ionelia Stan, Mara Amalia Balteanu, Ramona Cioboata, Alice Elena Ghenea, Suzana Danoiu, Ana-Maria Bumbea, Viorel Biciusca
Diagnostics.2023; 13(21): 3316. CrossRef Quantitative ultrasound envelope statistics imaging as a screening approach for pediatric hepatic steatosis and liver fibrosis: using biomarker and transient elastography as reference standards
Chiao-Shan Hsieh, Ming-Wei Lai, Chien-Chang Chen, Hsun-Chin Chao, Chiao-Yin Wang, Yung-Liang Wan, Zhuhuang Zhou, Po-Hsiang Tsui
Heliyon.2023; 9(12): e22743. CrossRef Alcohol consumption and the risk of liver disease: a nationwide, population-based study
Sang Yi Moon, Minkook Son, Yeo Wool Kang, Myeongseok Koh, Jong Yoon Lee, Yang Hyun Baek
Frontiers in Medicine.2023;[Epub] CrossRef
|